Teriparatide [RHPTH (1-34)] treatment reduces the incidence of back pain in postmenopausal women with osteoporosis

被引：0
|
作者：
Krege, JH
Xie, L
Genant, HK
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] UCSF, San Francisco, CA USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [21] Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis
    Zanchetta, JR
    Bogado, CE
    Ferretti, JL
    Wang, O
    Wilson, MG
    Sato, M
    Gaich, GA
    Dalsky, GP
    Myers, SL
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (03) : 539 - 543
  • [22] The managing your osteoporosis (MYO) program for patients starting therapy with teriparatide injection [rhPTH (1-34)]
    Drews, T.
    Valentine, V.
    Wong, M.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 1085 - 1085
  • [23] Bisphosphonates affect signaling pathways utilized by teriparatide [rhPTH(1-34)].
    Sun, Q
    Katz, RW
    Morris, SA
    Bilezikian, JP
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S230 - S231
  • [24] Comparison of Efficacy of Teriparatide (Parathyroid Hormone 1-34) Alone and in Combination with Zoledronic Acid for Osteoporosis in Postmenopausal Women
    Wei, Kang
    Qu, Yuxing
    Gao, Yi
    Ma, Yong
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (02): : 240 - 242
  • [25] Comparative analysis of the cost-effectiveness of teriparatide [RHPTH(1-34)] versus RHPTH(1-84)
    Borgstroem, F.
    Stroem, O.
    Kutahov, A.
    Marin, F.
    Ljunggren, O.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A396 - A396
  • [26] Changes in BMD at different skeletal sites after discontinuation of treatment with rhPTH (1-34) in postmenopausal osteoporotic women
    Zanchetta, JR
    Rubio, L
    Mango, A
    Bogado, CE
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S32 - S32
  • [27] Review: Teriparatide reduces fractures in postmenopausal women with osteoporosis
    Johnson, Bruce E.
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 157 (06)
  • [28] TERIPARATIDE REDUCES INCIDENCE OF NEW VERTEBRAL FRACTURES AND BACK PAIN ON POSTMENOPAUSAL WOMEN FOLLOWING VERTEBROPLASTY: A CASE SERIES
    Stanciu, M.
    Ristea, R. P.
    Peretianu, D.
    Popa, F. L.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S395 - S396
  • [29] Effect of raloxifene after recombinant teriparatide [hPTH(1–34)] treatment in postmenopausal women with osteoporosis
    S. Adami
    J. San Martin
    M. Muñoz-Torres
    M. J. Econs
    L. Xie
    G. P. Dalsky
    M. McClung
    D. Felsenberg
    J. P. Brown
    M. L. Brandi
    A. Sipos
    [J]. Osteoporosis International, 2008, 19 : 87 - 94
  • [30] Nonuremic calciphylaxis precipitated by teriparatide [rhPTH(1-34)] therapy in the setting of chronic warfarin and glucocorticoid treatment
    Spanakis, E. K.
    Sellmeyer, D. E.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 (04) : 1411 - 1414
12345